Nasdaq · Common stock
First Tracks Biotherapeutics (TRAX)
$43.48 −$0.57 (−1.29%)
- Day’s range
- $41.83–$45.42
- Volume
- 592,262
TRAX price history
TRAX closed at $43.48 on Oct. 26, 2026. Over the past year, its daily close ranged from $15.32 on June 3, 2026 to $47.92 on Aug. 10, 2026.
Data table: TRAX daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $43.48 |
| Oct. 23, 2026 | $44.05 |
| Oct. 22, 2026 | $43.14 |
| Oct. 21, 2026 | $42.77 |
| Oct. 20, 2026 | $41.25 |
| Oct. 19, 2026 | $36.28 |
| Oct. 16, 2026 | $34.46 |
| Oct. 15, 2026 | $36.04 |
| Oct. 14, 2026 | $34.13 |
| Oct. 13, 2026 | $31.68 |
| Oct. 12, 2026 | $34.05 |
| Oct. 9, 2026 | $31.85 |
| Oct. 8, 2026 | $32.01 |
| Oct. 7, 2026 | $30.59 |
| Oct. 6, 2026 | $31.39 |
| Oct. 5, 2026 | $32.99 |
| Oct. 2, 2026 | $33.28 |
| Oct. 1, 2026 | $33.92 |
| Sept. 30, 2026 | $35.44 |
| Sept. 29, 2026 | $35.98 |
| Sept. 28, 2026 | $36.65 |
| Sept. 25, 2026 | $34.42 |
| Sept. 24, 2026 | $35.83 |
| Sept. 23, 2026 | $36.66 |
| Sept. 22, 2026 | $41.03 |
| Sept. 21, 2026 | $38.99 |
| Sept. 18, 2026 | $38.60 |
| Sept. 17, 2026 | $39.20 |
| Sept. 16, 2026 | $39.00 |
| Sept. 15, 2026 | $38.47 |
| Sept. 14, 2026 | $37.57 |
| Sept. 11, 2026 | $36.44 |
| Sept. 10, 2026 | $37.98 |
| Sept. 9, 2026 | $39.57 |
| Sept. 8, 2026 | $41.80 |
| Sept. 4, 2026 | $40.46 |
| Sept. 3, 2026 | $42.51 |
| Sept. 2, 2026 | $45.28 |
| Sept. 1, 2026 | $41.17 |
| Aug. 31, 2026 | $41.84 |
| Aug. 28, 2026 | $41.86 |
| Aug. 27, 2026 | $44.74 |
| Aug. 26, 2026 | $44.19 |
| Aug. 25, 2026 | $45.11 |
| Aug. 24, 2026 | $43.28 |
| Aug. 21, 2026 | $43.11 |
| Aug. 20, 2026 | $41.90 |
| Aug. 19, 2026 | $45.50 |
| Aug. 18, 2026 | $43.88 |
| Aug. 17, 2026 | $43.60 |
| Aug. 14, 2026 | $44.04 |
| Aug. 13, 2026 | $44.03 |
| Aug. 12, 2026 | $46.13 |
| Aug. 11, 2026 | $46.75 |
| Aug. 10, 2026 | $47.92 |
| Aug. 7, 2026 | $45.33 |
| Aug. 6, 2026 | $45.31 |
| Aug. 5, 2026 | $46.95 |
| Aug. 4, 2026 | $46.01 |
| Aug. 3, 2026 | $46.16 |
| July 31, 2026 | $44.04 |
| July 30, 2026 | $47.78 |
| July 29, 2026 | $41.87 |
| July 28, 2026 | $41.85 |
| July 27, 2026 | $42.03 |
| July 24, 2026 | $35.52 |
| July 23, 2026 | $37.64 |
| July 22, 2026 | $38.17 |
| July 21, 2026 | $37.37 |
| July 20, 2026 | $36.87 |
| July 17, 2026 | $36.52 |
| July 16, 2026 | $36.21 |
| July 15, 2026 | $36.13 |
| July 14, 2026 | $34.37 |
| July 13, 2026 | $35.01 |
| July 10, 2026 | $36.24 |
| July 9, 2026 | $32.40 |
| July 8, 2026 | $20.77 |
| July 7, 2026 | $19.78 |
| July 6, 2026 | $20.04 |
| July 2, 2026 | $19.30 |
| July 1, 2026 | $18.59 |
| June 30, 2026 | $20.12 |
| June 29, 2026 | $17.01 |
| June 26, 2026 | $16.03 |
| June 25, 2026 | $16.37 |
| June 24, 2026 | $16.69 |
| June 23, 2026 | $17.78 |
| June 22, 2026 | $18.32 |
| June 18, 2026 | $17.42 |
| June 17, 2026 | $18.17 |
| June 16, 2026 | $17.14 |
| June 15, 2026 | $17.88 |
| June 12, 2026 | $17.64 |
| June 11, 2026 | $17.03 |
| June 10, 2026 | $16.42 |
| June 9, 2026 | $15.97 |
| June 8, 2026 | $15.75 |
| June 5, 2026 | $16.60 |
| June 4, 2026 | $18.20 |
| June 3, 2026 | $15.32 |
| June 2, 2026 | $16.14 |
| June 1, 2026 | $18.09 |
| May 29, 2026 | $15.96 |
| May 28, 2026 | $15.82 |
| May 27, 2026 | $16.14 |
| May 26, 2026 | $17.06 |
| May 22, 2026 | $17.18 |
| May 21, 2026 | $16.76 |
| May 20, 2026 | $16.17 |
| May 19, 2026 | $16.66 |
| May 18, 2026 | $17.79 |
| May 15, 2026 | $16.90 |
| May 14, 2026 | $18.16 |
| May 13, 2026 | $18.43 |
| May 12, 2026 | $17.81 |
| May 11, 2026 | $18.76 |
| May 8, 2026 | $19.54 |
| May 7, 2026 | $17.82 |
| May 6, 2026 | $20.25 |
| May 5, 2026 | $21.19 |
| May 4, 2026 | $20.55 |
| May 1, 2026 | $22.38 |
| April 30, 2026 | $23.27 |
| April 29, 2026 | $23.64 |
| April 28, 2026 | $20.05 |
| April 27, 2026 | $18.10 |
| April 24, 2026 | $18.16 |
| April 23, 2026 | $19.00 |
| April 22, 2026 | $18.87 |
| April 21, 2026 | $17.00 |
| April 20, 2026 | $18.60 |
Key figures
- Average daily volume
- 844,495Past 3 months
- Market value
- $1.55B
- Dividend yield
- —
Price change
- 1 month
- +26.32%
- 3 months
- +22.41%
What Wall Street says about TRAX
In the past 90 days, Wall Street firms published 13 rating or price-target actions on TRAX: 3 new ratings, 1 reiterated rating and 9 raised price targets.
| Action | Rating | |||
|---|---|---|---|---|
| Leerink Partners | Raises target | Outperform | $70 to $90 | |
| Canaccord Genuity | Raises target | Buy | $50 to $60 | |
| Evercore ISI Group | Raises target | Outperform | $65 to $70 | |
| Wells Fargo | Raises target | Overweight | $62 to $70 | |
| Canaccord Genuity | Initiates coverage | Buy | $50 | |
| Evercore ISI Group | Initiates coverage | Outperform | $65 | |
| Guggenheim | Initiates coverage | Buy | $100 | |
| HC Wainwright & Co. | Reiterates | Buy | $57 | |
| Barclays | Raises target | Overweight | $48 to $65 | |
| HC Wainwright & Co. | Raises target | Buy | $44 to $57 | |
| Piper Sandler | Raises target | Overweight | $54 to $95 | |
| Wedbush | Raises target | Outperform | $60 to $70 | |
| UBS | Raises target | Buy | $45 to $65 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About First Tracks Biotherapeutics, Inc. Ordinary Shares
First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.
- Headquarters
- San Diego, Calif.
- Listed
- April 6, 2026
- Sector
- Health care
- Industry
- Pharmaceutical preparations
In WallStreetDigest editions
No WallStreetDigest article about TRAX is on the site yet.